{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:23:18Z","timestamp":1793035398185,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["F31 AG074521"],"award-info":[{"award-number":["F31 AG074521"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01 AG067762"],"award-info":[{"award-number":["R01 AG067762"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["T32 GM142521"],"award-info":[{"award-number":["T32 GM142521"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01 NS082730"],"award-info":[{"award-number":["R01 NS082730"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Maibach-Smiley Endowment"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The progressive accumulation of pathological tau is a hallmark of Alzheimer\u2019s disease (AD). The bulk of existing\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    evidence suggests that pathological tau forms can seed further aggregation of the protein. However, many of the subsequent functional consequences following the formation of pathogenic tau aggregates are not yet fully understood. Here, we utilized the tau seeding phenomenon to induce the formation of pathogenic tau and identify intracellular consequences in a neuron culture model of AD-associated tauopathy. Primary neurons from human tau knock-in (MAPT-KI) mice were seeded with human AD brain-derived insoluble tau (AD-tau). Microscopy and biochemical assays were used to characterize the pathological tau species formed, as well as the extent of neuronal, axonal and synaptic degeneration in seeded MAPT-KI neurons. In addition, high-density microelectrode arrays were used to assess synaptic functionality in seeded MAPT-KI neuron cultures. Human-derived AD-tau seeded intracellular endogenous tau inclusions that contained AD-associated modifications (i.e. phosphorylation at the PHF1, AT8, and pS422 antibody epitopes) and adopted multiple pathogenic conformations (i.e. oligomers and exposure of an N-terminal phosphatase activating domain; PAD). Tau inclusions, containing pS422\u2009+\u2009and PAD-exposed tau, colocalized with active glycogen synthase kinase 3\u03b2 (the kinase involved in PAD-mediated axonal transport impairment) and accumulations of axonal transport cargo proteins (i.e. synaptophysin and amyloid precursor protein) in dystrophic axons. While there was no overt axonal degeneration or cell loss, intact excitatory synapses were reduced in the AD-tau neurons. Neuron cultures treated with AD-tau exhibited an N-methyl-D-aspartate receptor-dependent increase in network burst frequency when activated with glutamate as measured through high-density microelectrode arrays. Together, the data demonstrate that the AD-tau seeded MAPT-KI neuron model exhibits features associated with neuronal dysfunction resembling those that occur early in human disease (i.e. axonal pathology and dystrophy, hyperexcitability and hypersynchrony), without causing overt neurodegeneration.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-21920-8","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:13:17Z","timestamp":1761912797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Seeding Alzheimer\u2019s disease-associated tau pathology in MAPT knock-in primary neurons causes early axonopathy and synaptic dysfunction"],"prefix":"10.1038","volume":"15","author":[{"given":"Rebecca L.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"21920_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature23002","volume":"547","author":"AW Fitzpatrick","year":"2017","unstructured":"Fitzpatrick, A. W. et al. Cryo-EM structures of Tau filaments from Alzheimer\u2019s disease. Nature 547, 185\u2013190 (2017).","journal-title":"Nature"},{"key":"21920_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-014-1373-0","volume":"129","author":"S Boluda","year":"2015","unstructured":"Boluda, S. et al. Differential induction and spread of Tau pathology in young PS19 Tau transgenic mice following intracerebral injections of pathological Tau from Alzheimer\u2019s disease or corticobasal degeneration brains. Acta Neuropathol. 129, 221\u2013237 (2015).","journal-title":"Acta Neuropathol."},{"key":"21920_CR3","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1301175110","volume":"110","author":"F Clavaguera","year":"2013","unstructured":"Clavaguera, F. et al. Brain homogenates from human Tauopathies induce Tau inclusions in mouse brain. Proc. Natl. Acad. Sci. U S A. 110, 9535\u20139540 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"21920_CR4","doi-asserted-by":"publisher","first-page":"11485","DOI":"10.1523\/JNEUROSCI.2393-17.2017","volume":"37","author":"GS Gibbons","year":"2017","unstructured":"Gibbons, G. S. et al. GFP-Mutant human Tau transgenic mice develop tauopathy following CNS injections of Alzheimer\u2019s brain-derived pathological Tau or synthetic mutant human Tau fibrils. J. Neurosci. 37, 11485\u201311494 (2017).","journal-title":"J. Neurosci."},{"key":"21920_CR5","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1084\/jem.20160833","volume":"213","author":"JL Guo","year":"2016","unstructured":"Guo, J. L. et al. Unique pathological Tau conformers from Alzheimer\u2019s brains transmit Tau pathology in nontransgenic mice. J. Exp. Med. 213, 2635\u20132654 (2016).","journal-title":"J. Exp. Med."},{"key":"21920_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.neuron.2016.09.055","volume":"92","author":"SK Kaufman","year":"2016","unstructured":"Kaufman, S. K. et al. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo. Neuron 92, 796\u2013812 (2016).","journal-title":"Neuron"},{"key":"21920_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/srep00700","volume":"2","author":"CA Lasagna-Reeves","year":"2012","unstructured":"Lasagna-Reeves, C. A. et al. Alzheimer brain-derived Tau oligomers propagate pathology from endogenous Tau. Sci. Rep. 2, 700 (2012).","journal-title":"Sci. Rep."},{"key":"21920_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-023-02600-1","volume":"146","author":"A De Mate","year":"2023","unstructured":"De Mate, A. et al. Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric Tau. Acta Neuropathol. 146, 191\u2013210 (2023).","journal-title":"Acta Neuropathol."},{"key":"21920_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnagi.2019.00034","volume":"11","author":"J Miao","year":"2019","unstructured":"Miao, J. et al. Pathological Tau from Alzheimer\u2019s brain induces Site-Specific hyperphosphorylation and SDS- and reducing agent-resistant aggregation of Tau in vivo. Front. Aging Neurosci. 11, 34 (2019).","journal-title":"Front. Aging Neurosci."},{"key":"21920_CR10","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1523\/JNEUROSCI.1230-17.2017","volume":"37","author":"S Narasimhan","year":"2017","unstructured":"Narasimhan, S. et al. Pathological Tau strains from human brains recapitulate the diversity of Tauopathies in nontransgenic mouse brain. J. Neurosci. 37, 11406\u201311423 (2017).","journal-title":"J. Neurosci."},{"key":"21920_CR11","doi-asserted-by":"publisher","first-page":"12754","DOI":"10.1074\/jbc.RA119.009487","volume":"294","author":"T Saito","year":"2019","unstructured":"Saito, T. et al. Humanization of the entire murine Mapt gene provides a murine model of pathological human Tau propagation. J. Biol. Chem. 294, 12754\u201312765 (2019).","journal-title":"J. Biol. Chem."},{"key":"21920_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41467-019-13787-x","volume":"11","author":"Z He","year":"2020","unstructured":"He, Z. et al. Transmission of tauopathy strains is independent of their isoform composition. Nat. Commun. 11, 7 (2020).","journal-title":"Nat. Commun."},{"key":"21920_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky, S. T. & Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann. Neurol. 27, 457\u2013464 (1990).","journal-title":"Ann. Neurol."},{"key":"21920_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/ana.410330209","volume":"33","author":"SW Scheff","year":"1993","unstructured":"Scheff, S. W. & Price, D. A. Synapse loss in the Temporal lobe in Alzheimer\u2019s disease. Ann. Neurol. 33, 190\u2013199 (1993).","journal-title":"Ann. Neurol."},{"key":"21920_CR15","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"SW Scheff","year":"2007","unstructured":"Scheff, S. W., Price, D. A., Schmitt, F. A., DeKosky, S. T. & Mufson, E. J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501\u20131508 (2007).","journal-title":"Neurology"},{"key":"21920_CR16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.neurobiolaging.2005.09.012","volume":"27","author":"SW Scheff","year":"2006","unstructured":"Scheff, S. W., Price, D. A., Schmitt, F. A. & Mufson, E. J. Hippocampal synaptic loss in early Alzheimer\u2019s disease and mild cognitive impairment. Neurobiol. Aging. 27, 1372\u20131384 (2006).","journal-title":"Neurobiol. Aging"},{"key":"21920_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0675-9","volume":"7","author":"KR Christensen","year":"2019","unstructured":"Christensen, K. R., Beach, T. G., Serrano, G. E. & Kanaan, N. M. Pathogenic Tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways. Acta Neuropathol. Commun. 7, 1\u201321 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"21920_CR18","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1126\/science.1105681","volume":"307","author":"GB Stokin","year":"2005","unstructured":"Stokin, G. B. et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer\u2019s disease. Science 307, 1282\u20131288 (2005).","journal-title":"Science"},{"key":"21920_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0006-8993(93)91063-X","volume":"625","author":"JH Su","year":"1993","unstructured":"Su, J. H., Cummings, B. J. & Cotman, C. W. Identification and distribution of axonal dystrophic neurites in Alzheimer\u2019s disease. Brain Res. 625, 228\u2013237 (1993).","journal-title":"Brain Res."},{"key":"21920_CR20","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1097\/00001756-199712010-00006","volume":"8","author":"F Dessi","year":"1997","unstructured":"Dessi, F., Colle, M. A., Hauw, J. J. & Duyckaerts, C. Accumulation of SNAP-25 immunoreactive material in axons of Alzheimer\u2019s disease. Neuroreport 8, 3685\u20133689 (1997).","journal-title":"Neuroreport"},{"key":"21920_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.neuron.2011.11.033","volume":"73","author":"A de Calignon","year":"2012","unstructured":"de Calignon, A. et al. Propagation of Tau pathology in a model of early Alzheimer\u2019s disease. Neuron 73, 685\u2013697 (2012).","journal-title":"Neuron"},{"key":"21920_CR22","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1523\/JNEUROSCI.5245-10.2011","volume":"31","author":"A Sydow","year":"2011","unstructured":"Sydow, A. et al. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in Transgenic mice after switching off the toxic Tau mutant. J. Neurosci. 31, 2511\u20132525 (2011).","journal-title":"J. Neurosci."},{"key":"21920_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama, Y. et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53, 337\u2013351 (2007).","journal-title":"Neuron"},{"key":"21920_CR24","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1023\/B:NEUR.0000021904.61387.95","volume":"32","author":"WL Lin","year":"2003","unstructured":"Lin, W. L., Lewis, J., Yen, S. H., Hutton, M. & Dickson, D. W. Ultrastructural neuronal pathology in Transgenic mice expressing mutant (P301L) human Tau. J. Neurocytol. 32, 1091\u20131105 (2003).","journal-title":"J. Neurocytol"},{"key":"21920_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00429-010-0295-4","volume":"216","author":"AE Ludvigson","year":"2011","unstructured":"Ludvigson, A. E., Luebke, J. I., Lewis, J. & Peters, A. Structural abnormalities in the cortex of the rTg4510 mouse model of tauopathy: a light and electron microscopy study. Brain Struct. Funct. 216, 31\u201342 (2011).","journal-title":"Brain Struct. Funct."},{"key":"21920_CR26","doi-asserted-by":"publisher","first-page":"976","DOI":"10.2353\/ajpath.2007.070345","volume":"171","author":"K Leroy","year":"2007","unstructured":"Leroy, K. et al. Early axonopathy preceding neurofibrillary tangles in mutant Tau Transgenic mice. Am. J. Pathol. 171, 976\u2013992 (2007).","journal-title":"Am. J. Pathol."},{"key":"21920_CR27","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s004010051148","volume":"99","author":"A Probst","year":"2000","unstructured":"Probst, A. et al. Axonopathy and amyotrophy in mice Transgenic for human four-repeat Tau protein. Acta Neuropathol. 99, 469\u2013481 (2000).","journal-title":"Acta Neuropathol."},{"key":"21920_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neurobiolaging.2016.07.015","volume":"47","author":"K Cox","year":"2016","unstructured":"Cox, K. et al. Analysis of isoform-specific Tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport Inhibition. Neurobiol. Aging. 47, 113\u2013126 (2016).","journal-title":"Neurobiol. Aging"},{"key":"21920_CR29","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.1523\/JNEUROSCI.0560-11.2011","volume":"31","author":"NM Kanaan","year":"2011","unstructured":"Kanaan, N. M. et al. Pathogenic forms of Tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases. J. Neurosci. 31, 9858\u20139868 (2011).","journal-title":"J. Neurosci."},{"key":"21920_CR30","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1007\/s12035-023-03281-3","volume":"60","author":"KR Christensen","year":"2023","unstructured":"Christensen, K. R. et al. Phosphomimetics at Ser199\/Ser202\/Thr205 in Tau impairs axonal transport in rat hippocampal neurons. Mol. Neurobiol. 60, 3423\u20133438 (2023).","journal-title":"Mol. Neurobiol."},{"key":"21920_CR31","doi-asserted-by":"publisher","first-page":"9431","DOI":"10.1523\/JNEUROSCI.1914-20.2021","volume":"41","author":"B Combs","year":"2021","unstructured":"Combs, B. et al. Frontotemporal Lobar dementia mutant Tau impairs axonal transport through a protein phosphatase 1\u03b3-dependent mechanism. J. Neurosci. 41, 9431\u20139451 (2021).","journal-title":"J. Neurosci."},{"key":"21920_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.neurobiolaging.2011.06.006","volume":"33","author":"NM Kanaan","year":"2012","unstructured":"Kanaan, N. M. et al. Phosphorylation in the amino terminus of Tau prevents Inhibition of anterograde axonal transport. Neurobiol. Aging. 33, 826 (2012). e815-826. e830.","journal-title":"Neurobiol. Aging"},{"key":"21920_CR33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/jnr.21850","volume":"87","author":"NE LaPointe","year":"2009","unstructured":"LaPointe, N. E. et al. The amino terminus of Tau inhibits kinesin-dependent axonal transport: implications for filament toxicity. J. Neurosci. Res. 87, 440\u2013451 (2009).","journal-title":"J. Neurosci. Res."},{"key":"21920_CR34","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.expneurol.2016.06.030","volume":"283","author":"CT Tiernan","year":"2016","unstructured":"Tiernan, C. T. et al. Pseudophosphorylation of Tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport. Exp. Neurol. 283, 318\u2013329 (2016).","journal-title":"Exp. Neurol."},{"key":"21920_CR35","doi-asserted-by":"publisher","first-page":"10222","DOI":"10.1523\/JNEUROSCI.2250-06.2006","volume":"26","author":"KA Celone","year":"2006","unstructured":"Celone, K. A. et al. Alterations in memory networks in mild cognitive impairment and Alzheimer\u2019s disease: an independent component analysis. J. Neurosci. 26, 10222\u201310231 (2006).","journal-title":"J. Neurosci."},{"key":"21920_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson, B. C. et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65, 404\u2013411 (2005).","journal-title":"Neurology"},{"key":"21920_CR37","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos, S. L. et al. Antisense reduction of Tau in adult mice protects against seizures. J. Neurosci. 33, 12887\u201312897 (2013).","journal-title":"J. Neurosci."},{"key":"21920_CR38","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1523\/JNEUROSCI.3191-12.2013","volume":"33","author":"JK Holth","year":"2013","unstructured":"Holth, J. K. et al. Tau loss attenuates neuronal network hyperexcitability in mouse and drosophila genetic models of epilepsy. J. Neurosci. 33, 1651\u20131659 (2013).","journal-title":"J. Neurosci."},{"key":"21920_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jnc.12967","volume":"132","author":"HC Hunsberger","year":"2015","unstructured":"Hunsberger, H. C., Rudy, C. C., Batten, S. R., Gerhardt, G. A. & Reed, M. N. P301L Tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway. J. Neurochem. 132, 169\u2013182 (2015).","journal-title":"J. Neurochem"},{"key":"21920_CR40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.15252\/embr.201541438","volume":"17","author":"S Maeda","year":"2016","unstructured":"Maeda, S. et al. Expression of A152T human Tau causes age-dependent neuronal dysfunction and loss in Transgenic mice. EMBO Rep. 17, 530\u2013551 (2016).","journal-title":"EMBO Rep."},{"key":"21920_CR41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson, E. D. et al. Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on Tau levels in multiple mouse models of Alzheimer\u2019s disease. J. Neurosci. 31, 700\u2013711 (2011).","journal-title":"J. Neurosci."},{"key":"21920_CR42","doi-asserted-by":"publisher","first-page":"1265151","DOI":"10.3389\/fnagi.2023.1265151","volume":"15","author":"MJ Benskey","year":"2023","unstructured":"Benskey, M. J. et al. Behavioral and neuropathological characterization over the adult lifespan of the human Tau knock-in mouse. Front. Aging Neurosci. 15, 1265151 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"21920_CR43","doi-asserted-by":"crossref","unstructured":"Mueller, R. L., Kanaan, N. M. & Combs, B. Using Live-Cell imaging to measure the effects of pathological proteins on axonal transport in primary hippocampal neurons. J Vis. Exp (2023).","DOI":"10.3791\/66156"},{"key":"21920_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nbd.2016.05.016","volume":"94","author":"B Combs","year":"2016","unstructured":"Combs, B., Hamel, C. & Kanaan, N. M. Pathological conformations involving the amino terminus of Tau occur early in Alzheimer\u2019s disease and are differentially detected by monoclonal antibodies. Neurobiol. Dis. 94, 18\u201331 (2016).","journal-title":"Neurobiol. Dis."},{"key":"21920_CR45","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1021\/bi061325g","volume":"45","author":"PM Horowitz","year":"2006","unstructured":"Horowitz, P. M., LaPointe, N., Guillozet-Bongaarts, A. L., Berry, R. W. & Binder, L. I. N-terminal fragments of Tau inhibit full-length Tau polymerization in vitro. Biochemistry 45, 12859\u201312866 (2006).","journal-title":"Biochemistry"},{"key":"21920_CR46","first-page":"390","volume":"60","author":"D Caccamo","year":"1989","unstructured":"Caccamo, D. et al. Immunohistochemistry of a spontaneous murine ovarian teratoma with neuroepithelial differentiation. Neuron-associated beta-tubulin as a marker for primitive neuroepithelium. Lab. Invest. 60, 390\u2013398 (1989).","journal-title":"Lab. Invest."},{"key":"21920_CR47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1749-6632.1986.tb38392.x","volume":"466","author":"LI Binder","year":"1986","unstructured":"Binder, L. I., Frankfurter, A. & Rebhun, L. I. Differential localization of MAP-2 and Tau in mammalian neurons in situ. Ann. N Y Acad. Sci. 466, 145\u2013166 (1986).","journal-title":"Ann. N Y Acad. Sci."},{"key":"21920_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1523\/JNEUROSCI.04-02-00394.1984","volume":"4","author":"A Caceres","year":"1984","unstructured":"Caceres, A. et al. Differential subcellular localization of tubulin and the microtubule-associated protein MAP2 in brain tissue as revealed by immunocytochemistry with monoclonal Hybridoma antibodies. J. Neurosci. 4, 394\u2013410 (1984).","journal-title":"J. Neurosci."},{"key":"21920_CR49","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1046\/j.1471-4159.1994.63062336.x","volume":"63","author":"N Kalcheva","year":"1994","unstructured":"Kalcheva, N., Albala, J. S., Binder, L. I. & Shafit-Zagardo, B. Localization of specific epitopes on human microtubule-associated protein 2. J. Neurochem. 63, 2336\u20132341 (1994).","journal-title":"J. Neurochem"},{"key":"21920_CR50","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1523\/JNEUROSCI.08-12-04503.1988","volume":"8","author":"RP Tucker","year":"1988","unstructured":"Tucker, R. P., Binder, L. I., Viereck, C., Hemmings, B. A. & Matus, A. I. The sequential appearance of low- and high-molecular-weight forms of MAP2 in the developing cerebellum. J. Neuroscience: Official J. Soc. Neurosci. 8, 4503\u20134512 (1988).","journal-title":"J. Neuroscience: Official J. Soc. Neurosci."},{"key":"21920_CR51","doi-asserted-by":"crossref","unstructured":"Narasimhan, S. & Lee, V. M. The use of mouse models to study cell-to-cell transmission of pathological tau. In Methods in cell biology. Volume 141: Elsevier; 287\u2013305 (2017).","DOI":"10.1016\/bs.mcb.2017.06.009"},{"key":"21920_CR52","doi-asserted-by":"publisher","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","volume":"286","author":"KR Patterson","year":"2011","unstructured":"Patterson, K. R. et al. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J. Biol. Chem. 286, 23063\u201323076 (2011).","journal-title":"J. Biol. Chem."},{"key":"21920_CR53","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3233\/JAD-131235","volume":"37","author":"SM Ward","year":"2013","unstructured":"Ward, S. M. et al. TOC1: Characterization of a selective oligomeric Tau antibody. J. Alzheimers Dis. 37, 593\u2013602 (2013).","journal-title":"J. Alzheimers Dis."},{"key":"21920_CR54","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S0021-9258(18)48531-6","volume":"267","author":"S Greenberg","year":"1992","unstructured":"Greenberg, S., Davies, P., Schein, J. & Binder, L. Hydrofluoric acid-treated Tau PHF proteins display the same biochemical properties as normal Tau. J. Biol. Chem. 267, 564\u2013569 (1992).","journal-title":"J. Biol. Chem."},{"key":"21920_CR55","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1073\/pnas.1630428100","volume":"100","author":"TC Gamblin","year":"2003","unstructured":"Gamblin, T. C. et al. Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. USA. 100, 10032\u201310037 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"21920_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fnmol.2016.00123","volume":"9","author":"T Grabinski","year":"2016","unstructured":"Grabinski, T. & Kanaan, N. M. Novel non-phosphorylated serine 9\/21 GSK3beta\/alpha antibodies: Expanding the tools for studying GSK3 regulation. Front. Mol. Neurosci. 9, 123 (2016).","journal-title":"Front. Mol. Neurosci."},{"key":"21920_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/bs.mcb.2017.06.005","volume":"141","author":"B Combs","year":"2017","unstructured":"Combs, B., Tiernan, C. T., Hamel, C. & Kanaan, N. M. Production of recombinant Tau oligomers in vitro. Methods Cell. Biol. 141, 45\u201364 (2017).","journal-title":"Methods Cell. Biol."},{"key":"21920_CR58","doi-asserted-by":"publisher","first-page":"32789","DOI":"10.1074\/jbc.271.51.32789","volume":"271","author":"G Carmel","year":"1996","unstructured":"Carmel, G., Mager, E. M., Binder, L. I. & Kuret, J. The structural basis of monoclonal antibody Alz50\u2019s selectivity for Alzheimer\u2019s disease pathology. J. Biol. Chem. 271, 32789\u201332795 (1996).","journal-title":"J. Biol. Chem."},{"key":"21920_CR59","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1073\/pnas.92.22.10369","volume":"92","author":"P LoPresti","year":"1995","unstructured":"LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P. & Binder, L. I. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes. Proc. Natl. Acad. Sci. USA. 92, 10369\u201310373 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"21920_CR60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1023\/B:NEUR.0000044190.96426.b9","volume":"33","author":"RW Berry","year":"2004","unstructured":"Berry, R. W. et al. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. J. Neurocytol. 33, 287\u2013295 (2004).","journal-title":"J. Neurocytol"},{"key":"21920_CR61","doi-asserted-by":"crossref","unstructured":"Verstraelen, P. et al. Systematic quantification of synapses in primary neuronal culture. iScience 23, 101542 (2020).","DOI":"10.1016\/j.isci.2020.101542"},{"key":"21920_CR62","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","volume":"9","author":"M Goedert","year":"1990","unstructured":"Goedert, M. & Jakes, R. Expression of separate isoforms of human Tau protein: Correlation with the Tau pattern in brain and effects on tubulin polymerization. EMBO J. 9, 4225\u20134230 (1990).","journal-title":"EMBO J."},{"key":"21920_CR63","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang, Y. & Mandelkow, E. Tau in physiology and pathology. Nat. Rev. Neurosci. 17, 22\u201335 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"21920_CR64","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0165-3806(03)00056-7","volume":"142","author":"H Takuma","year":"2003","unstructured":"Takuma, H., Arawaka, S. & Mori, H. Isoforms changes of Tau protein during development in various species. Brain Res. Dev. Brain Res. 142, 121\u2013127 (2003).","journal-title":"Brain Res. Dev. Brain Res."},{"key":"21920_CR65","doi-asserted-by":"publisher","first-page":"E4376","DOI":"10.1073\/pnas.1411649111","volume":"111","author":"BB Holmes","year":"2014","unstructured":"Holmes, B. B. et al. Proteopathic Tau seeding predicts Tauopathy in vivo. Proc. Natl. Acad. Sci. U S A. 111, E4376\u20134385 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"21920_CR66","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.ajpath.2017.01.019","volume":"187","author":"B Combs","year":"2017","unstructured":"Combs, B. & Kanaan, N. M. Exposure of the amino terminus of Tau is a pathological event in multiple tauopathies. Am. J. Pathol. 187, 1222\u20131229 (2017).","journal-title":"Am. J. Pathol."},{"key":"21920_CR67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jnen\/nlv001","volume":"75","author":"NM Kanaan","year":"2016","unstructured":"Kanaan, N. M. et al. Characterization of early pathological Tau conformations and phosphorylation in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 75, 19\u201334 (2016).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"21920_CR68","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.neurobiolaging.2004.09.019","volume":"26","author":"AL Guillozet-Bongaarts","year":"2005","unstructured":"Guillozet-Bongaarts, A. L. et al. Tau Truncation during neurofibrillary tangle evolution in Alzheimer\u2019s disease. Neurobiol. Aging. 26, 1015\u20131022 (2005).","journal-title":"Neurobiol. Aging"},{"key":"21920_CR69","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/nature08890","volume":"464","author":"A de Calignon","year":"2010","unstructured":"de Calignon, A. et al. Caspase activation precedes and leads to tangles. Nature 464, 1201\u20131204 (2010).","journal-title":"Nature"},{"key":"21920_CR70","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00401-008-0431-x","volume":"116","author":"J Luna-Munoz","year":"2008","unstructured":"Luna-Munoz, J. et al. Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer\u2019s disease in tissue imprints. Acta Neuropathol. 116, 507\u2013515 (2008).","journal-title":"Acta Neuropathol."},{"key":"21920_CR71","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fncel.2020.00247","volume":"14","author":"NI Luna-Viramontes","year":"2020","unstructured":"Luna-Viramontes, N. I. et al. PHF-core Tau as the potential initiating event for Tau pathology in Alzheimer\u2019s disease. Front. Cell. Neurosci. 14, 247 (2020).","journal-title":"Front. Cell. Neurosci."},{"key":"21920_CR72","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/BF00294259","volume":"89","author":"R Mena","year":"1995","unstructured":"Mena, R., Edwards, P., Perez-Olvera, O. & Wischik, C. M. Monitoring pathological assembly of Tau and beta-amyloid proteins in Alzheimer\u2019s disease. Acta Neuropathol. 89, 50\u201356 (1995).","journal-title":"Acta Neuropathol."},{"key":"21920_CR73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jneumeth.2016.03.004","volume":"266","author":"A Kneynsberg","year":"2016","unstructured":"Kneynsberg, A., Collier, T. J., Manfredsson, F. P. & Kanaan, N. M. Quantitative and semi-quantitative measurements of axonal degeneration in tissue and primary neuron cultures. J. Neurosci. Methods. 266, 32\u201341 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"21920_CR74","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00401-002-0528-6","volume":"104","author":"E Adamec","year":"2002","unstructured":"Adamec, E., Mohan, P., Vonsattel, J. P. & Nixon, R. A. Calpain activation in neurodegenerative diseases: Confocal immunofluorescence study with antibodies specifically recognizing the active form of Calpain 2. Acta Neuropathol. 104, 92\u2013104 (2002).","journal-title":"Acta Neuropathol."},{"key":"21920_CR75","doi-asserted-by":"publisher","first-page":"9222","DOI":"10.1523\/JNEUROSCI.1132-14.2014","volume":"34","author":"MV Rao","year":"2014","unstructured":"Rao, M. V. et al. Specific calpain inhibition by calpastatin prevents Tauopathy and neurodegeneration and restores normal lifespan in Tau P301L mice. J. Neurosci. 34, 9222\u20139234 (2014).","journal-title":"J. Neurosci."},{"key":"21920_CR76","doi-asserted-by":"publisher","first-page":"27283","DOI":"10.1038\/srep27283","volume":"6","author":"Y Yin","year":"2016","unstructured":"Yin, Y. et al. Accumulation of human full-length Tau induces degradation of nicotinic acetylcholine receptor alpha4 via activating calpain-2. Sci. Rep. 6, 27283 (2016).","journal-title":"Sci. Rep."},{"key":"21920_CR77","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1021\/bi2009147","volume":"50","author":"KR Patterson","year":"2011","unstructured":"Patterson, K. R. et al. Heat shock protein 70 prevents both Tau aggregation and the inhibitory effects of preexisting Tau aggregates on fast axonal transport. Biochemistry 50, 10300\u201310310 (2011).","journal-title":"Biochemistry"},{"key":"21920_CR78","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/emboj\/21.3.281","volume":"21","author":"G Morfini","year":"2002","unstructured":"Morfini, G., Szebenyi, G., Elluru, R., Ratner, N. & Brady, S. T. Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 21, 281\u2013293 (2002).","journal-title":"EMBO J."},{"key":"21920_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40478-019-0675-9","volume":"7","author":"KR Christensen","year":"2019","unstructured":"Christensen, K. R., Beach, T. G., Serrano, G. E. & Kanaan, N. M. Pathogenic Tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways. Acta Neuropathol. Commun. 7, 29 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"21920_CR80","doi-asserted-by":"publisher","first-page":"32066","DOI":"10.1074\/jbc.M805300200","volume":"283","author":"S Jeganathan","year":"2008","unstructured":"Jeganathan, S. et al. Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of Tau and generates a pathological (MC-1) conformation. J. Biol. Chem. 283, 32066\u201332076 (2008).","journal-title":"J. Biol. Chem."},{"key":"21920_CR81","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1471-4159.2006.03784.x","volume":"97","author":"AL Guillozet-Bongaarts","year":"2006","unstructured":"Guillozet-Bongaarts, A. L. et al. Pseudophosphorylation of Tau at Serine 422 inhibits caspase cleavage: In vitro evidence and implications for tangle formation in vivo. J. Neurochem. 97, 1005\u20131014 (2006).","journal-title":"J. Neurochem."},{"key":"21920_CR82","doi-asserted-by":"publisher","first-page":"9623","DOI":"10.1523\/JNEUROSCI.1590-19.2019","volume":"39","author":"GI Hallinan","year":"2019","unstructured":"Hallinan, G. I., Vargas-Caballero, M., West, J. & Deinhardt, K. Tau misfolding efficiently propagates between individual intact hippocampal neurons. J. Neurosci. 39, 9623\u20139632 (2019).","journal-title":"J. Neurosci."},{"key":"21920_CR83","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1006\/nbdi.1999.0279","volume":"7","author":"K Duff","year":"2000","unstructured":"Duff, K. et al. Characterization of pathology in Transgenic mice over-expressing human genomic and cDNA Tau transgenes. Neurobiol. Dis. 7, 87\u201398 (2000).","journal-title":"Neurobiol. Dis."},{"key":"21920_CR84","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/nrn1788","volume":"6","author":"M Coleman","year":"2005","unstructured":"Coleman, M. Axon degeneration mechanisms: commonality amid diversity. Nat. Rev. Neurosci. 6, 889\u2013898 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"21920_CR85","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0896-6273(00)00124-0","volume":"28","author":"A Kamal","year":"2000","unstructured":"Kamal, A., Stokin, G. B., Yang, Z., Xia, C. H. & Goldstein, L. S. Axonal transport of amyloid precursor protein is mediated by direct binding to the Kinesin light chain subunit of Kinesin-I. Neuron 28, 449\u2013459 (2000).","journal-title":"Neuron"},{"key":"21920_CR86","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1073\/pnas.87.4.1561","volume":"87","author":"EH Koo","year":"1990","unstructured":"Koo, E. H. et al. Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport. Proc. Natl. Acad. Sci. U S A. 87, 1561\u20131565 (1990).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"21920_CR87","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11068-006-8726-0","volume":"34","author":"WL Lin","year":"2005","unstructured":"Lin, W. L. et al. Progressive white matter pathology in the spinal cord of Transgenic mice expressing mutant (P301L) human Tau. J. Neurocytol. 34, 397\u2013410 (2005).","journal-title":"J. Neurocytol"},{"key":"21920_CR88","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera, F. et al. Transmission and spreading of tauopathy in Transgenic mouse brain. Nat. Cell Biol. 11, 909\u2013913 (2009).","journal-title":"Nat. Cell Biol."},{"key":"21920_CR89","doi-asserted-by":"publisher","first-page":"e12231","DOI":"10.1002\/trc2.12231","volume":"7","author":"T Omoluabi","year":"2021","unstructured":"Omoluabi, T. et al. Novelty-like activation of locus coeruleus protects against deleterious human pretangle Tau effects while stress-inducing activation worsens its effects. Alzheimers Dement. (N Y). 7, e12231 (2021).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"21920_CR90","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1016\/j.ajpath.2016.06.008","volume":"186","author":"E Audouard","year":"2016","unstructured":"Audouard, E. et al. High-molecular-weight paired helical filaments from Alzheimer brain induces seeding of Wild-Type mouse Tau into an argyrophilic 4R Tau pathology in vivo. Am. J. Pathol. 186, 2709\u20132722 (2016).","journal-title":"Am. J. Pathol."},{"key":"21920_CR91","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1006\/neur.1996.0056","volume":"5","author":"ST DeKosky","year":"1996","unstructured":"DeKosky, S. T., Scheff, S. W. & Styren, S. D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5, 417\u2013421 (1996).","journal-title":"Neurodegeneration"},{"key":"21920_CR92","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1002\/ana.410340309","volume":"34","author":"SW Scheff","year":"1993","unstructured":"Scheff, S. W., Sparks, L. & Price, D. A. Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer\u2019s disease. Ann. Neurol. 34, 356\u2013361 (1993).","journal-title":"Ann. Neurol."},{"key":"21920_CR93","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580 (1991).","journal-title":"Ann. Neurol."},{"key":"21920_CR94","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neulet.2006.09.021","volume":"409","author":"O Katsuse","year":"2006","unstructured":"Katsuse, O., Lin, W. L., Lewis, J., Hutton, M. L. & Dickson, D. W. Neurofibrillary tangle-related synaptic alterations of spinal motor neurons of P301L Tau Transgenic mice. Neurosci. Lett. 409, 95\u201399 (2006).","journal-title":"Neurosci. Lett."},{"key":"21920_CR95","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/cne.23234","volume":"521","author":"KJ Kopeikina","year":"2013","unstructured":"Kopeikina, K. J. et al. Synaptic alterations in the rTg4510 mouse model of tauopathy. J. Comp. Neurol. 521, 1334\u20131353 (2013).","journal-title":"J. Comp. Neurol."},{"key":"21920_CR96","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nbd.2017.06.005","volume":"106","author":"P Reilly","year":"2017","unstructured":"Reilly, P. et al. Novel human neuronal Tau model exhibiting neurofibrillary tangles and transcellular propagation. Neurobiol. Dis. 106, 222\u2013234 (2017).","journal-title":"Neurobiol. Dis."},{"key":"21920_CR97","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.nlm.2010.12.005","volume":"95","author":"A Van der Jeugd","year":"2011","unstructured":"Van der Jeugd, A. et al. Hippocampal Tauopathy in Tau Transgenic mice coincides with impaired hippocampus-dependent learning and memory, and attenuated late-phase long-term depression of synaptic transmission. Neurobiol. Learn. Mem. 95, 296\u2013304 (2011).","journal-title":"Neurobiol. Learn. Mem."},{"key":"21920_CR98","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns, C. E. G. et al. TREM2 function impedes Tau seeding in neuritic plaques. Nat. Neurosci. 22, 1217\u20131222 (2019).","journal-title":"Nat. Neurosci."},{"key":"21920_CR99","doi-asserted-by":"crossref","unstructured":"Bassil, F. et al. Lee VM: alpha-Synuclein modulates Tau spreading in mouse brains. J Exp. Med 218. (2021).","DOI":"10.1084\/jem.20192193"},{"key":"21920_CR100","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3233\/JAD-201002","volume":"79","author":"T Hayashi","year":"2021","unstructured":"Hayashi, T. et al. Learning deficits accompanied by microglial proliferation after the long-term post-injection of Alzheimer\u2019s disease brain extract in mouse brains. J. Alzheimers Dis. 79, 1701\u20131711 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"21920_CR101","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","volume":"12","author":"H Targa Dias Anastacio","year":"2022","unstructured":"Targa Dias Anastacio, H., Matosin, N. & Ooi, L. Neuronal hyperexcitability in Alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 12, 257 (2022).","journal-title":"Transl Psychiatry"},{"key":"21920_CR102","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop, J. J. & Mucke, L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat. Rev. Neurosci. 17, 777\u2013792 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"21920_CR103","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awab442","volume":"145","author":"KG Ranasinghe","year":"2022","unstructured":"Ranasinghe, K. G. et al. Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early-onset Alzheimer\u2019s disease. Brain 145, 744\u2013753 (2022).","journal-title":"Brain"},{"key":"21920_CR104","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3233\/JAD-170925","volume":"63","author":"A Horvath","year":"2018","unstructured":"Horvath, A. et al. Prevalence, semiology, and risk factors of epilepsy in Alzheimer\u2019s disease: an ambulatory EEG study. J. Alzheimers Dis. 63, 1045\u20131054 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"21920_CR105","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","volume":"132","author":"AA Horvath","year":"2021","unstructured":"Horvath, A. A. et al. Subclinical epileptiform activity accelerates the progression of Alzheimer\u2019s disease: A long-term EEG study. Clin. Neurophysiol. 132, 1982\u20131989 (2021).","journal-title":"Clin. Neurophysiol."},{"key":"21920_CR106","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.4330","volume":"23","author":"AD Lam","year":"2017","unstructured":"Lam, A. D. et al. Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease. Nat. Med. 23, 678\u2013680 (2017).","journal-title":"Nat. Med."},{"key":"21920_CR107","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","volume":"95","author":"AD Lam","year":"2020","unstructured":"Lam, A. D. et al. Association of epileptiform abnormalities and seizures in Alzheimer disease. Neurology 95, e2259\u2013e2270 (2020).","journal-title":"Neurology"},{"key":"21920_CR108","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2017.11.005","volume":"63","author":"U Smailovic","year":"2018","unstructured":"Smailovic, U. et al. Quantitative EEG power and synchronization correlate with Alzheimer\u2019s disease CSF biomarkers. Neurobiol. Aging. 63, 88\u201395 (2018).","journal-title":"Neurobiol. Aging"},{"key":"21920_CR109","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","volume":"70","author":"KA Vossel","year":"2013","unstructured":"Vossel, K. A. et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol. 70, 1158\u20131166 (2013).","journal-title":"JAMA Neurol."},{"key":"21920_CR110","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","volume":"80","author":"KA Vossel","year":"2016","unstructured":"Vossel, K. A. et al. Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease. Ann. Neurol. 80, 858\u2013870 (2016).","journal-title":"Ann. Neurol."},{"key":"21920_CR111","doi-asserted-by":"publisher","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters, C. L. et al. Alzheimer\u2019s disease. Nat. Rev. Dis. Primers. 1, 15056 (2015).","journal-title":"Nat. Rev. Dis. Primers"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21920-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21920-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21920-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:03:14Z","timestamp":1762300994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21920-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":111,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21920"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21920-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38140"}}